A blog maintained by Tevita Kete, PGR Officer Secretariat of the Pacific Community (SPC), Suva, Fiji Islands
|
||||
This weblog documents the activities of Pacific Agricultural Genetic Resources Network (PAPGREN), along with other information on plant genetic resources (PGR) in the Pacific. The myriad varieties found within cultivated plants are fundamental to the present and future productivity of agriculture. PAPGREN, which is coordinated by the Land Resources Division of the Secretariat of the Pacific Community (SPC), helps Pacific countries and territories to conserve their crop genetic diversity sustainably, with technical assistance from the Bioversity International (BI) and support from NZAID and ACIAR. SPC also hosts the Centre of Pacific Crops and Trees (CEPaCT). The CEPaCT maintains regional in vitro collections of crops important to the Pacific and carries out research on tissue culture technology. The CEPaCT Adviser is Dr Mary Taylor (MaryT@spc.int), the CEPaCT Curator is Ms Valerie Tuia (ValerieT@spc.int).
PAPGREN coordination and support
PAPGREN partners Mr William Wigmore Mr Adelino S. Lorens Dr Lois Englberger Mr Apisai Ucuboi Dr Maurice Wong Mr Tianeti Beenna Ioane Mr Frederick Muller Mr Herman Francisco Ms Rosa Kambuou Ms Laisene Samuelu Mr Jimi Saelea Mr Tony Jansen Mr Finao Pole Mr Frazer Bule Lehi Other CROP agencies Pacific biodiversity Other Pacific organizations Pacific news Interested in GIS?
|
Thursday, July 13, 2006 Posted 3:17 PM by Luigi
Tongan bark may hold diabetes key Source: Melbourne Herald Sun – Australia, 8 June 2006 Melbourne biotechnology company Dia-B Tech believes it has found a natural alternative to the anti-diabetes drug insulin in the bark of a plant found in Tongan rainforests. Chief executive Ken Smith is tight-lipped on details, preferring not to disclose the name of the vine until the company has a provisional patent over its use. "But what I can tell you is that plant has been used by traditional healers in Tonga to heal type two diabetes and obesity over hundreds of years," Mr Smith said. "They mix it with a potion of various plants and tree barks which are ground, mixed with water and taken orally with great results." The company has been testing the bark since February last year, today announcing to the Australian Stock Exchange that preliminary results were looking good. Dr Ken Walder, a scientist with Intramed, another biotech company involved in the research, said it was already clear the natural derivative had a component with "very strong" insulin-like qualities. When developed commercially, the component would be used by people with type two diabetes, a metabolic disorder that occurs when the pancreas is not producing enough insulin. The medical and commercial potential would be significant if further research confirmed the component effectively acts as a natural `proxy' for insulin, Mr Smith said. More than one million Australians are estimated to have type two diabetes, with researchers predicting this figure will treble by 2051. For full story, please see: www.heraldsun.news.com.au/common/story_page/0,5478,19406257%255E1702,00.html |
Archive RSS Feed Alternative feed Contact Tevita
Something new: Agrobiodiversity Weblog: For discussions of conservation and sustainable use of the genetic resources of crops, livestock and their wild relatives.
PestNet: For on-line
information, advice and pest identification for the Pacific and beyond.
Contact: Grahame Jackson.
Pacific Mapper: For on-line
mapping of point data over satellite images of the Pacific provided by Google Maps.
DIVA-GIS: For free, easy-to-use
software for the spatial analysis of biodiversity data.
|